X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases
暂无分享,去创建一个
Michael W. Wilson | A. Mesecar | Y. M. Báez-Santos | N. M. Davis | S. Baker | Susan C. Baker | S. Larsen | Anna M. Mielech | Andrew D. Mesecar | A. Mielech | Nicole M. Davis | Yahira M. Báez-Santos | Scott J. Barraza | Michael P. Agius | Scott D. Larsen | M. Wilson
[1] E. Freire,et al. The binding of HIV-1 protease inhibitors to human serum proteins. , 2003, Biophysical chemistry.
[2] E. Purisima,et al. Deubiquitination, a New Function of the Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease? , 2005, Journal of Virology.
[3] Katrina Sleeman,et al. Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease. , 2009, Journal of medicinal chemistry.
[4] Robert Ménard,et al. Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease , 2007, Archives of Biochemistry and Biophysics.
[5] R. Pebody,et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[6] R. Copeland. Determination of serum protein binding affinity of inhibitors from analysis of concentration-response plots in biochemical activity assays. , 2000, Journal of pharmaceutical sciences.
[7] T. Welte,et al. [SARS--Severe Acute Respiratory syndrome]. , 2003, Pneumologie.
[8] U. Emirates. b Middle East respiratory syndrome coronavirus (MERS-CoV): update , 2014 .
[9] Arun K. Ghosh,et al. Synergistic Inhibitor Binding to the Papain‐Like Protease of Human SARS Coronavirus: Mechanistic and Inhibitor Design Implications , 2013, ChemMedChem.
[10] M. Catchpole,et al. Novel coronavirus associated with severe respiratory disease: case definition and public health measures. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[11] Raymond C Stevens,et al. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[12] Wentao Fu,et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication , 2008, Proceedings of the National Academy of Sciences.
[13] Zhongbin Chen,et al. Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus , 2007, Journal of Biological Chemistry.
[14] B. Berkhout,et al. Croup Is Associated with the Novel Coronavirus NL63 , 2005, PLoS medicine.
[15] Kui Li,et al. Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune Response through Disruption of STING-Mediated Signaling , 2012, PloS one.
[16] Debbie C. Mulhearn,et al. Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation. , 2010, Journal of medicinal chemistry.
[17] R. Pebody,et al. The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[18] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[19] John Bechill,et al. Identification of Severe Acute Respiratory Syndrome Coronavirus Replicase Products and Characterization of Papain-Like Protease Activity , 2004, Journal of Virology.
[20] W. E. Barnette. The synthesis and biology of fluorinated prostacyclins. , 1984, CRC critical reviews in biochemistry.
[21] R. Ménard,et al. The Papain-Like Protease from the Severe Acute Respiratory Syndrome Coronavirus Is a Deubiquitinating Enzyme , 2005, Journal of Virology.
[22] Alexander E. Gorbalenya,et al. Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans , 2012, mBio.
[23] E. Hodgson,et al. Interaction of methylenedioxyphenyl (1,3-benzodioxole) compounds with enzymes and their effects on mammals. , 1974, Drug metabolism reviews (Softcover ed.).
[24] Zhongbin Chen,et al. The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity , 2005, Journal of Virology.
[25] R. Sorenson,et al. Novel inhibitors of bacterial virulence: development of 5,6-dihydrobenzo[h]quinazolin-4(3H)-ones for the inhibition of group A streptococcal streptokinase expression. , 2013, Bioorganic & medicinal chemistry.
[26] B. Rha. Update: Severe Respiratory Illness Associated with a Novel Coronavirus — Worldwide, 2012–2013 , 2013, MMWR. Morbidity and mortality weekly report.
[27] Alexei Vagin,et al. Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.
[28] T. Tong,et al. Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections. , 2009, Infectious disorders drug targets.
[29] Christian Drosten,et al. Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.
[30] V. Mićović,et al. The Reduction of Acid Amides with Lithium Aluminum Hydride , 1953 .
[31] Martyn D Winn,et al. Macromolecular TLS refinement in REFMAC at moderate resolutions. , 2003, Methods in enzymology.
[32] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[33] Jincun Zhao,et al. Human Coronavirus EMC Is Not the Same as Severe Acute Respiratory Syndrome Coronavirus , 2013, mBio.
[34] C. F. Wilkinson,et al. Mechanism of the metabolism of 1,3-benzodioxoles to carbon monoxide. , 1984, Biochemical pharmacology.
[35] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[36] R. Geffers,et al. Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential , 2013, mBio.
[37] B. Cowling,et al. Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[38] T. Peters,et al. All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .
[39] F. Lichtenberger,et al. Abbreviations Used , 1979, Confronting the Bomb.
[40] U. Baumann,et al. An efficient one-step site-directed and site-saturation mutagenesis protocol. , 2004, Nucleic acids research.